OraSure receives FDA clearance for at-home STI urine collection kit
Go back to OraSure receives FDA clearance for at-home STI urine collection kit| OraSure Technologies, Inc. (NASDAQ: OSUR) | Delayed: 3.41 -0.07 (2.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.48 | 52 Week High | $9.05 | |||
| Open | $3.46 | 52 Week Low | $5.10 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.41 | EPS | $-0.20 | |||
| Volume | 95,939 | |||||
